We have also shown that loss of TET2 contributes to impaired luminal lineage commitment, promoted mammary tumor development with deficient ERα expression, and confers tamoxifen resistance in a Tet2 deletion-PyMT breast cancer mouse model. This evidence concerns the gene ESR1 and breast cancer.